Filter
3212
Filtered Results: 3212
Text search:
drug
supply
Featured
Recommendations
324
New Publications
1053
Language
Document type
No document type
1967
Studies & Reports
450
Guidelines
420
Manuals
149
Strategic & Response Plan
119
Training Material
42
Fact sheets
34
Situation Updates
16
Infographics
7
Resource Platforms
5
Brochures
1
App
1
Online Courses
1
Countries / Regions
India
235
Kenya
114
Ethiopia
106
Uganda
98
Global
96
Nigeria
78
South Africa
78
Tanzania
70
Nepal
69
Malawi
69
Sierra Leone
67
Liberia
65
Western and Central Europe
62
Myanmar / Burma
57
Zambia
56
Ghana
53
Bangladesh
52
Africa
41
Rwanda
36
Namibia
34
Philippines
32
Zimbabwe
30
Cambodia
28
Latin America and the Carribbean
28
Ukraine
27
Lesotho
26
Asia
26
Eastern Europe
25
South–East Asia Region
24
Syria
21
Botswana
21
Senegal
16
Indonesia
15
Burkina Faso
14
Congo, Democratic Republic of
14
Mozambique
13
East and Southern Africa
12
Russia
12
Eswatini/ Swaziland
11
Middle East and North Africa
11
South Sudan
10
Haiti
9
West and Central Africa
9
Eastern Europe and Central Asia
9
Georgia
9
Cameroon
8
Pakistan
8
Albania
8
Guinea
7
Sudan
7
Venezuela
7
Afghanistan
6
Thailand
6
Brazil
6
Western Pacific Region
6
Germany
5
Benin
5
Colombia
5
Laos
5
Vietnam
5
USA
4
Iraq
4
Lebanon
4
North Macedonia
4
Sri Lanka
4
Yemen
4
Tajikistan
4
Moldova
4
Jordan
3
Turkey
3
China
3
Argentina
3
Peru
3
Madagascar
3
Bhutan
3
Timor Leste/ East Timor
3
Kyrgyzstan
3
Jamaica
3
United Kingdom
3
Morocco
2
Saudi Arabia
2
Somalia
2
Papua New Guinea
2
Central African Republic
2
Hungary
2
Libya
2
Mexico
2
Paraguay
2
Fiji
2
Poland
2
Portugal
2
Guinea-Bissau
1
Gambia
1
Serbia
1
Honduras
1
Bolivia
1
Greece
1
Angola
1
Chile
1
Solomon Islands
1
Palestine
1
North Korea
1
Armenia
1
Canada
1
Bulgaria
1
Estonia
1
Iran
1
Uzbekistan
1
Australia
1
Kazakhstan
1
North America
1
Gabon
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
Tunisia
1
Norway
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
1514
Clinical Guidelines
295
Public Health
152
Women & Child Health
132
Key Resources
84
Pharmacy & Technologies
60
Capacity Building
45
Annual Report MEDBOX
1
Toolboxes
HIV
296
TB
263
Mental Health
168
AMR
168
COVID-19
162
Pharmacy
144
NTDs
87
Caregiver
74
NCDs
56
Rapid Response
54
Conflict
50
Planetary Health
49
Ebola
44
Global Health Education
33
Refugee
28
Disability
19
Health Financing Toolbox
19
Natural Hazards
17
Polio
15
Cholera
14
Specific Hazards
12
Social Ethics
7
Zika
6
Health Financing
1
Six months after its launch on 24 April, the Access to COVID-19 Tools (ACT) Accelerator has already delivered concrete results in speeding up the development of new therapeutics, diagnostics, and vaccines. Now mid-way through the scale-up phase, the tools we need to fundamentally change the course o...
I examine the effectiveness of donors in targeting the highest burden of malaria in the Democratic Republic of Congo when health information structure is fragmented. I exploit local variations in the burden of malaria induced by mining activities as well as financial and epidemiological data from he...
Development finance institutions owned by European governments and the World Bank Group are spending hundreds of millions of dollars on expensive for-profit hospitals in the Global South that block patients from getting care, or bankrupt them, with some even imprisoning patients who cannot afford th...
This report examines the support to private healthcare provision in India by the World Bank’s private sector arm, the International Finance Corporation (IFC). Despite supporting private healthcare in the country since 1997, no healthcare results for lending and investments have been disclosed sinc...
Strengthening resource tracking and monitorig health expanditure
This report makes clear that there is a path to end AIDS. Taking that path will help ensure preparedness to address other pandemic challenges, and advance progress across the Sustainable Development Goals. The data and real-world examples in the report make it very clear what that path is. It is not...
Multiple pandemics, numerous outbreaks, thousands of lives lost and billions of dollars of national income wiped out—all since the turn of this century, in barely 17 years—and yet the world’s investments in pandemic preparedness and response remain woefully inadequate. We know by now that the ...
While there has been real progress in addressing the burden of disease in the WHO African region, the COVID-19 pandemic has highlighted the link between health, economics and security, as the region saw decades of progress threatened, including positive trends in decreasing inequality. In the Africa...
This report compiles data for the first time on the far-reaching consequences of uncontrolled hypertension, including heart attacks, strokes and premature death, along with substantial economic losses for communities and countries. It also contains information on the global, regional and country-lev...
In an ambitious new era for health development under the 2030 Agenda for Sustainable Development, WHO and
its partners have a solid foundation of success on which to build. Health plays a fundamental role in development
and is the central focus of Sustainable Development Goal 3, “Ensure healthy ...
Significant progress has been made in the eradication of three priority diseases in the African Region, as a result of extensive collaboration between the Regional Office, WHO country offices and countries. For example, in August 2020, the region was certified free of wild poliovirus. In the area of...
This country cooperation strategy (CCS) outlines how the World Health Organization (WHO) will work with the Lao People’s Democratic Republic over the next five years (2024–2028), supporting the implementation of the five-year health sector development plans and the Health Sector Reform Strategy ...
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...
Cardiovascular diseases, principally ischemic heart disease (IHD), are the most important cause of death and disability in the majority of low- and lower-middle-income countries (LLMICs). In these countries, IHD mortality rates are significantly greater in individuals of a low socioeconomic status (...
Hypertension is referred to as a “silent killer”. Most people with hypertension are unaware of their condition as in most cases, they experience no warning signs or symptoms hence they are not identified or treated. Hypertention is associated with a number of conditions, disability, and causes o...
Many low- and middle-income countries (LMICs) are undergoing an epidemiological transition. With an improvement in socioeconomic conditions and an aging population, cardiovascular diseases (CVDs), like cardiac arrhythmias, are expected to increase in these countries. However, there are limited studi...
The cardiovascular disease continuum begins with risk factors such as diabetes mellitus (DM), progresses to vasculopathy and myocardial dysfunction, and finally ends with cardiovascular death. Diabetes is associated with a 2- to 4-fold increased risk for heart failure (HF). Moreover, HF patients wit...
WHO has published the first-ever guidance on the clinical management of diphtheria. The only previously available guidance was an operational protocol. The new guidance followed the rigorous process for developing guidance at WHO.
It addresses the use of Diphtheria Antitoxin (DAT) in the treatmen...
The purpose of this workbook is to assist ministries of health, health managers and practitioners in engaging with the private sector on delivery of quality maternal, newborn and child health (MNCH) services in lower- and middle-income countries. Private health care is one of the fastest growing seg...
Diabetes is a serious, chronic disease that occurs either when the pancreas does not produce enough insulin (a hormone that regulates blood sugar, or glucose), or when the body cannot effectively use the insulin it produces. Diabetes is an important public health problem, one of four priority noncom...
